T259 PILL Precautions

The T259 pill is a specific prescription pharmaceutical formulation manufactured by Aurobindo Pharma Limited, a major generic drug supplier. It is a combination medication containing two distinct active ingredients: Acetaminophen (a non-opioid analgesic and antipyretic) and Hydrocodone Bitartrate (a semi-synthetic opioid analgesic).

This particular formulation contains 325 mg of Acetaminophen and 7.5 mg of Hydrocodone Bitartrate. It is heavily regulated and classified under the Controlled Substances Act due to its potential for dependence and abuse.

The pill featuring the imprint T 259 is a combination prescription medication composed of Hydrocodone Bitartrate and Acetaminophen. It is a potent analgesic (pain reliever) prescribed primarily for the management of moderate to severe acute pain when alternative non-opioid treatments are inadequate.

Because it contains an opioid, this medication is classified as a Schedule II Controlled Substance in the United States, meaning it has a high potential for abuse, dependence, and addiction.